期刊文献+

Connexin43蛋白在良恶性前列腺组织中的表达差异 被引量:3

原文传递
导出
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2004年第12期1559-1559,共1页 Chinese Journal of Experimental Surgery
基金 南京军区医学科研"十五"计划课题(02MA025)
  • 相关文献

参考文献4

  • 1Murry SA,Davis K,Fishman LM,et al.Alphal connexin43 gap junction are decreased in human adrenocortical tumors.J Clin Endocrinol Metab,2000,85:890-895.
  • 2Habermann H,Ray V,Habermann W,et al.Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer.J Urol,2001,166:2267-2272.
  • 3Tsai H,Werber L,Davia MO,et al.Reduce connexin 43 expression in high grade,human prostatic adenocarcinoma cells.Biochem Biophys Res Commun,1996,227:64-69.
  • 4Mehta PP,Perez-Stable C,Nadji M,et al.Suppression of human prostate cancer cell growth by forced expression of connexin gene.Dev Gen,1999,24:91-110.

同被引文献24

  • 1洪涛,孙华,蒋丽萍,何安慰,卢明巍.全反式维甲酸诱导脑胶质瘤化疗的旁观者效应[J].中华实验外科杂志,2005,22(3):379-379. 被引量:6
  • 2Hemman JR, Adler HL, Aguilar-Cordova E, et al. In situ gene theray for adenocar- cinoma of the prostate: a phase I clinical trial. Hum Gene Ther, 1999,10 : 1239-1249.
  • 3Denning C, Pitts JD. Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different path ways for intercellular transfer toxic metabolites, a factor that will govern clinical choice of appropriate regimen. Hum Gene Ther, 1997,8 : 1825-1835.
  • 4Sanson M, Marcaud V, Robin E, et al. Connexin43-mediated bystander effect in two rat glioma cell models. Cancer Gene Ther, 2002, 9: 149-155.
  • 5Madersbacher S, Alivizatos G, Nordling J, et al. EAU 2004 guide- lines on assessment, therapy and follow-up of men with lower uri- nary tract symptoms suggestive of benign prostatic obstruction ( B PH guidelines). Eur Urol, 2004, 46 (5) : 547-554.
  • 6Robertson C, Link CL, Onel E, et al. The impact of lower uri- nary tract symptoms and comorbidities on quality of life: The BACH and UREPIK studies. BJU Int, 2007, 99(2) : 347-354.
  • 7Saigal CS, Joyce G. Economic costs of benign prostatic hyperpla- sia in the private sector. J Urol, 2005, 173(4) : 1309-1313.
  • 8Zhou Q, Liao JK. Statins and cardiovascular diseases : From cho- lesterol lowering to pleiotropy. Curr Pharm Des, 2009, 15 (5) : 467 -478.
  • 9St Sauver JL, Jacobson DJ, MeGree ME, et al. Protective associ- ation between nonsteroidal antiinflammatory drug use and mea- sures of benign prostatic hyperplasia. Am J Epidemiol, 2006, 164(8) : 760-768.
  • 10Sciarra A, Di Silverio F, Salciccia S, et al. Inflammation and chronic prostatic diseases: Evidence for a link? Eur Urol, 2007, 52(4) : 964-972.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部